Lieza D.
Co-founder, Chief Executive Officer @Liveritas Biosciences, Inc
Signup · Get unlimited contacts
WORK HISTORY
Co-founder, Chief Executive Officer @Liveritas Biosciences, Inc
South San Francisco, CA, US
LiVeritas Biosciences is the fastest and most accurate in the market in helping clients bring drugs from discovery to FDA approval. We\'ve already helped advance 10 drug candidates, after testing thousands, to clinical trials for cancer, cardiovascular and auto-immune diseases, to name a few. Using a proprietary AI-platform, it executes molecular testing 100x faster than their nearest competitors. We have won clients that collectively have over two billion dollars in market capitalization. Two of our earliest clients were recently acquired by big pharma as unicorns: ProfoundBio ($1.8Bn, Genmab, 2024) and Chinook Therapeutics ($3.2Bn, Novartis, 2023).The Founder CEO, Lieza Danan PhD, is Philippine born and educated in the University of California Davis, and has made a mark as a pioneer in the biopharma industry developing novel cancer drugs. She is a repeat founder and veteran of two prior unicorn biotech startups (Stemcentrx purchased by Abbvie for $6bn and Sutro Biopharma which IPOed on NASDAQ in 2018.) As a cancer survivor herself, this is a personal calling, and she is joined by the LiVeritas team on their mission to assist in developing safer and more efficacious drugs to extend and improve the lives of patients, especially their sick loved ones.
EDUCATION
Manila Science High School
Science High School, Scholarship & Silver Medalist, Honors/Regents High School/Secondary Diploma Program
Ateneo de Manila University
Master of Science - MS, Analytical Chemistry with Scholarship
Ateneo de Manila University
Bachelor of Science - BS, Chemistry (Honor's Program with Full Scholarship)
University of California, Davis
PhD, Biological Chemistry and Mass Spectrometry
ABOUT LIEZA D.
I’m a scientist-founder building the future of regulated testing, where agentic AI meets chemistry and data becomes decision.Before I became a cancer survivor, I was first a biopharma scientist. I helped build the bioanalytical workflows that brought novel protein therapeutics to market. For a decade, I worked 80-hour weeks wrangling fragmented tools and massive datasets to help advance the kind of drug that would later save my life. Karma paid it back.But the system that brings therapies to patients is still broken, too slow, too manual, too disconnected. So now, I am building the platform I wish existed 15 years ago.At LiVeritas, we’re turning raw lab chaos into FDA-grade reports, live, trusted, and already powering regulatory filings across the industry.I lived the pain. Now, at LiVeritas, we’re engineering the solution. Follow us to see how agentic AI is transforming regulated science.https://calendly.com/liezadanan/meet-greets
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.